Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BRKR · against 179 other Healthcare companies of similar size
Ranked #135 of 180 · scores higher than 23% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 30–39, including BRKR · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | BRKR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 179 reported | -1.2% | 2.6% | 24% | 30% | |
| EBITDA yieldHigher is better · 178 reported | 5.2% | 4.7% | 54% | 50% | |
| Free cash flow yieldHigher is better · 106 reported | 0.7% | 1.8% | 40% | 20% | |
| Book yieldHigher is better · 179 reported | 27.7% | 19.9% | 60% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 132 | 20.0B AUD (≈$13.2B) | 38 | 77 | |
| 132 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 9.1B USD |
| 38 |
| 74 |
| 135 | 14.87T KRW (≈$10.7B) | 37 | 76 |
| 135 | 5.2B USD | 37 | 74 |
| 135 | 8.6B USD | 37 | 30 |
| 135 | 10.1B USD | 37 | 61 |
| 139 | 16.5B USD | 36 | 37 |
| 140 | 6.1B USD | 33 |
| 140 | 4.5B USD | 33 | 33 |